BioSyent Inc. (BIOYF)
OTCMKTS: BIOYF · Delayed Price · USD
7.31
+0.72 (10.94%)
Jul 22, 2024, 4:00 PM EDT - Market closed

BioSyent Revenue

BioSyent had revenue of 32.84M CAD in the twelve months ending March 31, 2024, with 19.99% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 7.73M with 19.30% year-over-year growth. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.

Revenue (ttm)
32.84M CAD
Revenue Growth
+19.99%
P/S Ratio
3.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
86.21M undefined

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202331.59M3.67M13.12%
Dec 31, 202227.93M-693.03K-2.42%
Dec 31, 202128.62M6.29M28.15%
Dec 31, 202022.33M907.84K4.24%
Dec 31, 201921.42M-102.70K-0.48%
Dec 31, 201821.53M764.27K3.68%
Dec 31, 201720.76M2.84M15.85%
Dec 31, 201617.92M2.53M16.47%
Dec 31, 201515.39M3.18M26.02%
Dec 31, 201412.21M4.41M56.56%
Dec 31, 20137.80M2.78M55.24%
Dec 31, 20125.02M2.22M78.88%
Dec 31, 20112.81M1.13M67.06%
Dec 31, 20101.68M651.31K63.24%
Dec 31, 20091.03M-72.09K-6.54%
Dec 31, 20081.10M-2.33K-0.21%
Dec 31, 20071.10M-410.17K-27.08%
Dec 31, 20061.51M765.97K102.33%
Dec 31, 2005748.52K37.49K5.27%
Dec 31, 2004711.04K-101.81K-12.53%
Dec 31, 2003812.84K280.82K52.78%
Dec 31, 2002532.02K-133.91K-20.11%
Dec 31, 2001665.93K-221.38K-24.95%
Dec 31, 2000887.31K87.31K10.91%
Dec 31, 1999800.00K100.00K14.29%
Dec 31, 1998700.00K--
Dec 31, 1997700.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Eli Lilly 35.93B
Revenue Rankings